Warwick Tong

Direktor/Vorstandsmitglied bei AMPLIA THERAPEUTICS LIMITED

Vermögen: 236 597 $ am 30.06.2026

Health Technology

Consumer Services

Profil

Warwick Tong is currently Chairman at Biomedical Research Australia.
Other current roles include Independent Non-Executive Director at Amplia Therapeutics Ltd. starting in 2026, Director at Amplia Therapeutics Uk Ltd., Director at ACULEUS THERAPEUTICS PTY LTD, Director at Pacalis Therapeutics Pty Ltd., Member-Governance Board at Arc Centre For Excellence In Convergent Bio-Nano Science & Tec, and Member at Maurice Wilkins Centre.
Former positions include Chief Executive Officer & Director at Oncology One Pty Ltd. from 2011 to 2018, Chairman at CTxONE from 2018 to 2020, Chairman at Biomedical Research Victoria from 2018 to 2019, Medical Director at GlaxoSmithKline NZ Ltd. from 1993 to 1997, Medical Director at Glaxo Wellcome Manufacturing Pte Ltd., Senior Vice President-Development at Surface Logix LLC from 2010 to 2012, and Vice President-World Wide Development at GSK Plc.
Education includes graduation from Victoria University of Wellington.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
AMPLIA THERAPEUTICS LTD. 0,46 %	06.09.2025	2.355.140 ( 0,46 % )	236 597 $	30.06.2026

Aktive Positionen von Warwick Tong

Unternehmen	Position	Beginn
AMPLIA THERAPEUTICS LIMITED	Direktor/Vorstandsmitglied	30.06.2026
Biomedical Research Australia	Vorsitzender	-
Arc Centre For Excellence In Convergent Bio-Nano Science & Tec	Direktor/Vorstandsmitglied	-
Amplia Therapeutics Uk Ltd.	Direktor/Vorstandsmitglied	-
Maurice Wilkins Centre	Corporate Officer/Principal	-

Alle aktiven Positionen von Warwick Tong

Ehemalige bekannte Positionen von Warwick Tong

Unternehmen	Position	Ende
CTxONE	Vorstandsvorsitzender	-
Biomedical Research Victoria	Vorsitzender	01.12.2019
Oncology One Pty Ltd. Oncology One Pty Ltd. BiotechnologyHealth Technology Develops novel oncology drug and clinical diseases for cancer	Vorstandsvorsitzender	30.04.2018
Surface Logix LLC Surface Logix LLC Pharmaceuticals: MajorHealth Technology Manufactures molecular drugs	Corporate Officer/Principal	03.10.2012
░░░░░░░░░░░░░░░ ░░ ░░░░	░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░░░░░░░░░░

Sehen Sie sich die Erfahrung von Warwick Tong im Detail an

Ausbildung von Warwick Tong

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Warwick Tong im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	13
Surface Logix LLC Surface Logix LLC Pharmaceuticals: MajorHealth Technology Manufactures molecular drugs	Health Technology
Oncology One Pty Ltd. Oncology One Pty Ltd. BiotechnologyHealth Technology Develops novel oncology drug and clinical diseases for cancer	Health Technology
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
Victoria University of Wellington Victoria University of Wellington Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
GlaxoSmithkline NZ Ltd. GlaxoSmithkline NZ Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Glaxo Wellcome Manufacturing Pte Ltd. Glaxo Wellcome Manufacturing Pte Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Amplia Therapeutics Ltd. Amplia Therapeutics Ltd. BiotechnologyHealth Technology Develops drug candidates for oncology and chronic fibrosis	Health Technology
CTxONE
Biomedical Research Australia
Arc Centre For Excellence In Convergent Bio-Nano Science & Tec
Maurice Wilkins Centre
Biomedical Research Victoria
Amplia Therapeutics Uk Ltd.